CorporateInformation.com
 
Company Search:
Advanced Search
 
Sponsored Links
 
 
 
 
 
 
 
Dbv Technologies Company Snapshot
Dbv Technologies operates in the Pharmaceutical preparations sector. In addition to historical fundamental analyses, the complete report available to purchase compares Dbv Technologies with three other pharmaceutical manufacturers in Europe: Camurus AB of Sweden (2016 sales of 113.74 million Swedish Kronor [US$13.03 million] ), Unipharm AD of Bulgaria (17.70 million Bulgarian Lev [US$10.10 million] ), and Biotec Pharmacon ASA which is based in Norway (71.90 million Norwegian Kroner [US$8.56 million] ).

Sales Analysis. Dbv Technologies reported sales of 9.08 million Euro (US$10.14 million) for the year ending December of 2016. This represents an increase of 47.3% versus 2015, when the company's sales were 6.17 million Euro. Sales at Dbv Technologies have increased during each of the previous five years (and since 2011, sales have increased a total of 7,107%).
   
   
 
Company ReportsSubscriptions
 
Looking For More?
Purchace an In-Depth Report
Dbv Technologies
  Stock Performance Chart for Dbv Technologies
 
  Stock Data: Recent Stock Performance:
  Current Price (5/19/2017): 63.05
(Figures in Euro)
1 Week -2.4%   13 Weeks 3.4%  
4 Weeks -7.4%   52 Weeks 17.1%  
 
Dbv Technologies Key Data:
  Ticker: DBV Country: France
  Exchanges: PAR Major Industry: Pharmaceuticals & Biotechnology
    Sub Industry: Pharmaceutical Preparations
  2016 Sales 9,084,000
(Year Ending Jan 2017).
Employees: 164
  Currency: Euro Market Cap: 1,553,872,357
  Fiscal Yr Ends: December Shares Outstanding: 24,645,081
  Share Type: Ordinary Closely Held Shares:
 
 
Sponsored Links
 
 
 
 
Feedback | Terms and Conditions | Privacy Policy | Site Index
 
CorporateInformation® website and selected data Copyright © 2000 - by The Winthrop Corporation. All Rights Reserved. Except for quotations by established news media, no pages on this site may be reproduced, stored in a retrieval system, or transmitted for commercial purposes, in any form or by any means, electronic, mechanical, photocopying, recording, or otherwise without prior written permission. Information is believed reliable, but accuracy, completeness and opinions are not guaranteed.